Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PFKM inhibitors(phosphofructokinase, muscle inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19F3N2O3 |
InChIKeyZVKABNMPEGUGSJ-UHFFFAOYSA-N |
CAS Registry260798-40-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acidosis, Lactic | Discovery | JP | 04 Dec 2024 | |
Multiple Mitochondrial Dysfunctions Syndrome | Discovery | JP | 04 Dec 2024 |